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Several distinct subpopulations of bone marrow–derived liver progenitor cells were recently described.
However, there is inadequate information comparing these subpopulations from a liver-function point of
view. This study was undertaken to compare two subpopulations of liver progenitors: b2-microglobulin
(b2m)–negative/Thy-1–positive cells, and liver progenitors obtained from the non-adherent cell fraction
after a panning procedure. The cells were cultured under several conditions including high- and low-
dose hepatocyte growth factor, various cellular densities, and different media. Growth characteristics,
liver-specific metabolic capacity, and liver regeneration–associated gene expression were studied. Both
isolation procedures yielded cells that produced albumin and metabolized ammonia into urea. The study
demonstrated that the b2m-negative/Thy-1–positive cell fraction metabolized ammonia into urea more
efficiently and produced a superior amount of albumin compared with the panned cell fraction. The
b2m-negative/Thy-1–positive cell fraction could be optimal for the development of novel cell-based
treatment strategies for congenital or acquired liver diseases. ( J GASTROINTEST SURG 2005;9:1340–
1345)  2005 The Society for Surgery of the Alimentary Tract
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hepatocytes, cholangiocytes, and hepatic endothelial
cells under specific conditions.1–11 Recently, several
studies demonstrated that bone marrow–derived
adult liver stem cells could be activated and
mobilized from the bone marrow, on a specific
demand, generated by a failing liver. After activation,
these cells demonstrated exquisite ability to differ-
entiate into several cell lineages and provide hepatic
support.5,8,12,13 Consequently, this plasticity of adult
bone marrow cells elicited renewed enthusiasm in
developing novel treatment strategies for the caring
of congenital and acquired liver diseases.14 One
potential advantage of such an adult liver progenitor
cell is the possibility of use in an autogenic manner,
avoiding immunosuppression.
Currently, bone marrow–derived liver progenitors
are thought to be a heterogeneous group of cells.
This bone marrow fraction of cells is composed of 2005 The Society for Surgery of the Alimentary Tract
Published by Elsevier Inc.several different subpopulations, as reflected by the
diverse experimental strategies for their isolation,
characterization, and culturing.1,6,9,10,15–18 Adopting
the concept of a single pluripotent adult stem cell,
residing within the bone marrow, that carries
a potential capability to generate progeny of several
lineages with hepatocyte-associated function gave
the impetus to the search for an optimal sub-
population of cells that should be used to develop
novel cell therapy strategies.
As published recently by Oh et al.,16 a subpopula-
tion of putative liver progenitor cells can be isolated
from the bone marrow by a panning procedure.
When cultured for 21 days with initially high doses
of hepatocyte growth factor (HGF), these bone
marrow cells transformed into a hepatocyte lineage
as shown by the expression of albumin mRNA. In
a similar approach, Miyazaki et al.6 were able to
induce hepatocyte-specific mRNA expression inPresented at the Forty-Sixth Annual Meeting of The Society for Surgery of the Alimentary Tract, Chicago, IL, May 14–18, 2005 (poster
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HGF to the culture media.
A different approach to isolate adult liver pro-
genitor cells from the bone marrow was developed
by our group.1,15 After a two-step magnetic cell
sorting (MACS) immunoisolation procedure, b2-
microglobulin–negative, Thy-1 (CD-90)–positive
(b2m-negative/Thy-1–positive) cells (rodent and
human) were shown to express hepatocyte-specific
markers. Additionally, their hepatocyte-specific
metabolic activity was detectable both in culture
and in vivo.1,5,11,15
The aim of this study was to further characterize
and functionally compare these two promising pro-
genitor cell subpopulations. Prior to embarking on
developing novel cell therapy strategies for the care
of patients with failing livers, it is imperative to select
the optimal cell source. We demonstrate here that
the b2m-negative/Thy-1–positive cell fraction is an
attractive candidate to be used in such novel cell
therapies.
MATERIAL AND METHODS
All animal experimentation was approved by the
institutional committee for animal welfare in accor-
dance with the European Convention on Animal
Care. Twenty-eight male Sprague-Dawley rats (220–
250 g; RCC Ltd., Fu¨llinsdorf, Switzerland) were
divided into seven experimental groups (Table 1).
Cells from rat’s bone marrow were isolated either by
panning or by MACS, as described previously.1,15,16
Cells were then either plated onto a low- or a high-
density cellular culture on uncoated polystyrene
dishes or onto a layer of Matrigel (Becton Dickinson,
Bedfold, MA).1,15,16 Culture medium was either DF
medium, a 1:1 mixture of Ham’s F12 (GIBCO,Invitrogen Corporation, Paisley, Scotland, UK) and
Dulbecco’s modified Eagle’s medium (Sigma, Buchs,
Switzerland) supplemented with 1000 ng/ml of HGF
(R&D Systems, Minneapolis, MN) for 5 days,
followed by 5 ng/ml of HGF or DF medium
supplemented with 20 ng/ml of HGF for the entire
culture period of 12 days. Alternatively cells were
cultured in small hepatocyte media (SHM)19 with
10% heat-inactivated fetal calf serum (Invitrogen,
Basel, Switzerland) and supplemented with HGF (20
ng/ml) and epidermal growth factor (10 ng/ml;
Biosource, Camarillo, CA). The cells were cultured
in 500 ml of media for 12 days with a change of
medium every third day.
The Panning Procedure
Femoral bone marrow was harvested by aspiration
through an 18-gauge needle (Venflon; Becton Dick-
inson, Fraga, Spain) with a 1-ml syringe (Plastipak;
Becton Dickinson, Madrid, Spain) and transferred
into sterile phosphate-buffered saline. The bone
marrow pellet was gently drawn into and expelled
from the syringe 10 times to release the cells into
suspension. After red cell lysis, the remaining cells
were precultured in DF medium supplemented with
10% fetal bovine serum on a 60-mm polystyrene
dish (Corning Costar Corporation, Bodenheim,
Germany).16 After 60 minutes of panning, the
nonadherent cells were collected, washed with
serum-free DF medium, and plated.
The MACS Procedure
For the isolation of b2m-negative/Thy-1–positive
cells, the recently developed MACS procedure was
used as described recently by Avital et al.15 and










Medium Hepatocyte Growth Factor
PaL20 Panning 5000 None DF medium 20 ng/ml
MaL20 MACS 5000 None DF medium 20 ng/ml
PaL1000 Panning 5000 None DF medium 1000 ng/ml; Oday 6: 5 ng/ml
MaL1000 MACS 5000 None DF medium 1000 ng/ml; Oday 6: 5 ng/ml
PaH1000 Panning 50,000 None DF medium 1000 ng/ml; Oday 6: 5 ng/ml
PaHSHM Panning 50,000 Matrigel SHM 20 ng/ml
MaHSHM MACS 50,000 Matrigel SHM 20 ng/ml
Subpopulations of bone marrow cells were isolated by two different procedures: panning (Pa) and magnetic cell sorting of b2-microglobulin
negative/Thy-1–positive cells (Ma). The cells were plated using two different cell densities: L 5 5000 cells/cm2, H 5 50,000 cells/cm2, on
uncoated polystyrene dishes or on a layer of Matrigel, in small hepatocyte medium (SHM) or a mixure of Dulbecco’s modified Eagle medium
and Ham’s-F12 medium (DF medium) containing 1000 ng/ml (1000) of hepatocyte growth factor for 5 days and 5 ng/ml thereafter, or 20 ng/ml
(20) of HGF for the entire culture period.
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Culture Dishes
For all culture experiments, 24-well cell culture
plates were used (Corning Costar Corporation).
Where indicated, dishes were coated with a gel layer
of Matrigel (25 mg/cm2).1,15
Enzyme-Linked Immunosorbent Assay
(Albumin)
Albumin secretion was measured at culture days 3,
6, 9, and 12 by sandwich enzyme-linked immuno-
sorbent assay. Samples were analyzed in several
dilutions (1:1, 1:2, 1:5, 1:10) and compared with
a standard curve of rat albumin (RSA, Rat albumin
fraction V; ICN Biomedicals GmbH, Eschwege,
Germany).20
Determination of Urea Synthesis
Bone marrow derived liver progenitors were
spiked with ammonia (Sigma A 4514, 2.5 mmol/l,
pH 7.40) for 5 hours at 3, 6, 9, and 12 days of
culturing. Ammonia and urea content were then
immediately determined by the use of an enzymatic
colorimetric method (Roche Diagnostics, Rotkreuz,
Switzerland). The precision of the test in the
described experimental setting is 62.6% for ammo-
nia and 62.7% for urea.1,21
Total RNA Extraction
Cells were harvested by addition of 500 ml of
TRIZOL (Invitrogen AG) to the culture dish after
complete removal of the media immediately after
determination of urea formation. Total RNA was
extracted as described previously,22 and cDNA then
was synthesized with random primers, using the
Promega Reverse Transcription System (Promega
Corporation, Madison, WI).
Albumin, Multidrug Resistance Associated
Protein-1 (mrp-1), Multidrug Resistance
Associated Protein-2 (mrp-2) mRNA Expression
Quantitative mRNA expression was measured by
TaqMan real-time polymerase chain reaction (PCR)
using albumin, mrp-1, and mrp-2 primers and probes
as described.1,19 Standard TaqMan real-time PCR
conditions (Applied Biosystems, Rotkreuz, Switzer-
land) were used. The cycler conditions were set to
50 C for 2 minutes, followed by 50 cycles of the
amplification step (95 C for 15 seconds to activate
the Taq DNA polymerase and 60 C for 15 seconds
to anneal and extend the amplicon).18S rRNA Content
The content of 18S rRNA in each individual
culture dish was quantified by TaqMan real-time
PCR (AB Applied Biosystems). Average threshold
cycle values (CT values) from triplicate real-time
PCRs were obtained. Standardization of the meta-
bolic signal (e.g., urea formation or albumin secre-
tion) for total cell number was achieved by
the following formula: ðMetabolic signal=hrÞ=
ð2expð502CT value of 18S rRNAÞÞ.1,23 CT values of the
gene of interest were related to 18S rRNA con-
tent:






Results are expressed as mean 6 SD. Paired t test
was used to compare parallel cell cultures from the
same donor animal. Student’s t test was applied to
compare groups with normally distributed data. For
the correction of pairwise multiple comparisons, the
Student-Newman-Keuls method was applied. The
significance level was set at P ! .05.
RESULTS
In the first experiment, we examined whether
b2m-negative/Thy-1–positive cells attach within 60
minutes to a polystyrene culture dish. Of the cells
plated, 16.7%6 5.5% (n5 5) were nonadherent and
accordingly harvested in suspension, as described
previously after the panning procedure. In a sub-
sequent experiment, using the MACS procedure on
the nonadherent cell fraction, 6.5% 6 1.5% of cells
were identified as b2m-negative/Thy-1–positive.
ATP Binding Cassette Transporter Gene
Expression (mrp-1, mrp-2)
mrp-1 was expressed in both subpopulations (i.e.,
after panning and after the MACS procedure)
immediately after isolation. The corresponding
DCT values for mrp-1 were 13.7 6 0.2 for panned
cells and 12.9 6 3.4 for b2m-negative/Thy-1–
positive cells. After culturing, mrp-1 expression was
maintained in the PaHSHM group (see Table 1) for
12 days of culture (average DCT values, 11.5 6 0.7).
In contrast, in the MaHSHM group the mrp-1 signal
was not detectable.
No expression of mrp-2 mRNA was found in real-
time PCR in freshly isolated or cultured cells from
both cell isolation methods.
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Analyzing the total cell number of parallel cell
cultures (i.e., PaL20 with PaL1000; MaL20 with
MaL1000) in culture media containing different
amounts of HGF revealed no significant difference
in the panned groups, whereas cell number in the
MACS groups was significantly decreased in the
culture media with high HGF content (Table 2).
Albumin secretion or urea genesis was not detectable
in any of these four experimental conditions (Table 3).
Of note, high doses of HGF significantly reduced the
total amount of b2m-negative/Thy-1–positive cells in
culture, whereas no change in total cell number was
detected in the cells after panning.
Experimental Groups With High Density
of Plated Cells
Pairwise comparison of 18S rRNA content in the
high-density cultures (PaHSHM, PaH, MaSHM)
showed significant differences in the total number of
cells between all groups (Table 2). The highest cell
number was observed in panned cells cultured on
Matrigel in SHM (PaHSHM). Cell number was
stable over a culture period of 12 days (Table 2).
Urea genesis was maintained for 12 days and
albumin synthesis was detectable in the culture
media until culture day 9 (Table 3). The metabolic
capacity of the panned subpopulation on Matrigel in
SHM contrasts with the absence of any albumin
formation or urea genesis in the PaH1000 group.




Average CT values for 18S rRNA Content
3 days 6 days 9 days 12 days
PaL20 33 6 1.9 31 6 2.7 33 6 1.7 33 6 2.2
MaL20 32 6 3.0 32 6 2.2 33 6 2.7 34 6 4.7
PaL1000 32 6 2.6 31 6 3.4 33 6 2.4 31 6 2.5
MaL1000 37 6 1.3 35 6 6.3 36 6 0.9 36 6 1.8
PaH1000 28 6 1.2 30 6 5.0 29 6 1.8 29 6 0.5
PaHSHM 26 6 0.7 25 6 0.6 28 6 0.6 25 6 4.0
MaHSHM 34 6 0.7 35 6 0.6 37 6 1.4 37 6 1.8
For groups, see Table 1 footnotes.
No significant cell growth or cell loss was detected under any of the
seven experimental conditions examined over a period of 12 days. In
the low-density (L) cultures, high doses of hepatocyte growth factor
significantly reduced the total amount of cells in the groups after
MACS sorting (MaL20 versus MaL1000). Total cell numbers in all
three high-density (H) cultures (PaH1000, PaHSHM, MaHSHM)
were significantly different, indicating individual responses of the
isolated subpopulations to the different culture conditions.An intermediate cell number was seen in panned
cells cultured in DF medium with an initial amount
of 1000 ng/ml of HGF for 5 days (PaH1000). Cell
number was maintained over a total of 12 days in
culture (Table 2). Reduction of the HGF supple-
mented to 5 ng/ml did not influence the total
amount of cells in culture. With real-time PCR
analysis, albumin mRNA was detectable in minute
amounts in the PaH1000 group over time, but no
albumin secretion or urea formation was detectable
in the metabolic assays used (Table 3).
The lowest cell number was determined in the cell
cultures of b2m-negative/Thy-1–positive cells in
SHM (MaHSHM). Total cell number was main-
tained over time with a slight decrease after day 9 in
culture (Table 2). Albumin synthesis and urea
formation were evident over the entire culture
period of 12 days (Table 3).
DISCUSSION
The b2m-negative/Thy-1–positive bone marrow
cells do not attach efficiently to a polystyrene dish.
In fact, b2m-negative/Thy-1–positive cells can be
enriched by the panning procedure alone in the
nonadherent cell fraction by an average of around
240%.1
mrp-1 expression in normal liver is low.24
However, in regenerating livers25 and in rodent
livers after an oval cell induction protocol, mrp-1
specific staining was observed.24 We therefore
















PaL20 ND !DL !DL
MaL20 ND !DL !DL
PaL1000 ND !DL !DL
MaL1000 ND !DL !DL
PaH1000 D !DL !DL
PaHSHM D D D
MaHSHM D D D
For groups, see Table 1 footnotes.
Albumin secretion and urea genesis were determined in the seven
experimental groups. Only the high-density cultures on a layer of
Matrigel in small hepatocyte media showed albumin secretion (D)
and urea formation (D). High doses of hepatocyte growth factor
induced albumin mRNA expression in bone marrow cells after
panning as described, but no urea synthesis or albumin secretion was
observed in this group (!DL, values below detection limit). Albumin
mRNA was not determined (ND) in the metabolically quiescent
experimental groups.
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bone marrow subpopulations obtained by panning
and after the MACS procedure. mrp-1 was expressed
in both subpopulations immediately after isolation.
The mrp-1 signal was then maintained only in the
PaHSHM group for the entire culture period of 12
days. It is possible that the cells obtained after
MACS have more ‘‘liver-like’’ gene expression and
therefore express less mrp-1.
mrp-2 is expressed in the canalicular membrane of
highly differentiated hepatocytes.19 No expression of
mrp-2 mRNA was found in real-time PCR in freshly
isolated or cultured cells from both cell isolation
methods. This is congruent with our assumption
that both populations of cells are not well differen-
tiated. Moreover, due to the lack of expression of
mrp-1 and mrp-2 in the MaHSHM subpopulation,
containing freshly isolated b2m-negative/Thy-1–
positive cells, we submit that this subpopulation of
cells after culturing in SHM contain cells in a less-
differentiated state.
Bone marrow subpopulations obtained by differ-
ent cell isolation procedures 1,6–10,17,18,26 are likely to
overlap and the amount of liver progenitor cells
contained within these individual cell isolations
could therefore vary considerably. Careful surface
marker and liver specific functional analysis of the
various cell populations physiologically present in
the bone marrow is urgently needed.
To compare the liver specific functional capacity
and the individual response of the two subpopula-
tions to HGF, a series of in vitro studies were
performed (Table 1).
As described by Oh et al.,16 the panning cell
isolation procedure yields a subpopulation of cells
from the bone marrow that expresses albumin mRNA
when cultured with high doses of HGF. However, in
our series the high content of HGF in the DF medium
did not propagate hepatocyte specific metabolic
activities as demonstrated by the lack of albumin
synthesis or urea formation. In a direct comparison,
b2m-negative/Thy-1–positive cells (MaHSHM) out-
performed the panned cells (PaHSHM) significantly
(Table 4). Albumin expression on the mRNA level
corresponded well with the albumin secretion de-
termined in the culture medium. The culture medium
described induces strong hepatocyte specific meta-
bolic activity in a pure culture of b2m-negative/Thy-
1–positive bone marrow cells. A 1:20 co-culture of
b2m-negative/Thy-1–positive cells with uncharacter-
ized bone marrow cells (PaHSHM) resulted in rapid
loss of the liver specific metabolic capacity while total
cell number was maintained.
High doses of HGF6,16 significantly reduced the
total amount of b2m-negative/Thy-1–positive cellsin culture while no change in total cell number was
detected in the cells after panning. We concluded
that high-dose HGF is potentially toxic to b2m-
negative/Thy-1–positive cells, whereas it has lesser
effect on the panned cell population. One explana-
tion could be based on the heterogeneity of the
panned cells.
Characterizing hormonally defined culture media
for unlimited cell expansion of b2m-negative/Thy-1–
positive cells represents the next crucial step for the
development of future cell-based liver therapy.
CONCLUSION
Both cell isolation procedures yielded a subpopu-
lation of bone marrow–derived liver progenitors
capable of hepatocyte specific metabolic activity.
Pure cell preparation of b2m-negative/Thy-1–posi-
tive cells showed significantly stronger albumin
synthesis and urea formation than did cells after
panning. Culture conditions to propagate the un-
limited cell expansion of liver progenitor cells would
make it possible to use this cell pool for the
development of novel adult progenitor cell–based
treatment strategies. This approach might prove to
be clinically valuable for the cure of congenital or
acquired liver diseases.
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